• LAST PRICE
    3.2950
  • TODAY'S CHANGE (%)
    Trending Up0.0450 (1.3846%)
  • Bid / Lots
    3.2900/ 12
  • Ask / Lots
    3.3000/ 5
  • Open / Previous Close
    3.2500 / 3.2500
  • Day Range
    Low 3.2500
    High 3.3100
  • 52 Week Range
    Low 2.5700
    High 6.0900
  • Volume
    170,021
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 3.25
TimeVolumeCRMD
09:32 ET80823.27
09:35 ET6003.26
09:37 ET8003.27
09:39 ET95343.28
09:42 ET13153.2701
09:44 ET3993.27
09:46 ET15353.2739
09:48 ET1003.285
09:50 ET1203.275
09:53 ET13003.26
09:55 ET3003.26
10:06 ET64053.27
10:08 ET6003.28
10:11 ET12003.265
10:13 ET14003.2601
10:18 ET10003.2635
10:20 ET21503.255
10:24 ET10003.255
10:27 ET29283.255
10:31 ET3393.256
10:36 ET11003.255
10:38 ET20003.2517
10:49 ET8003.255
10:51 ET1073.255
10:56 ET40923.27
11:02 ET10003.265
11:05 ET34673.275
11:07 ET12683.27
11:12 ET1003.27
11:16 ET18003.275
11:18 ET12003.275
11:21 ET9003.28
11:25 ET5053.2791
11:27 ET93583.295
11:30 ET105863.29
11:36 ET3013.3
11:38 ET234733.3
11:39 ET66073.305
11:43 ET6003.305
11:45 ET2003.305
11:50 ET1003.305
11:52 ET107093.295
11:59 ET17223.295
12:01 ET1003.29
12:08 ET1003.295
12:10 ET1003.295
12:12 ET34243.31
12:14 ET6003.305
12:17 ET1003.305
12:19 ET20003.3002
12:21 ET22013.3
12:24 ET1043.305
12:26 ET2003.31
12:28 ET6003.31
12:30 ET33803.305
12:32 ET1003.3
12:35 ET1503.3043
12:37 ET10003.305
12:39 ET1003.305
12:42 ET1003.3
12:44 ET3003.304
12:46 ET2003.305
12:50 ET1003.305
12:51 ET3003.305
12:53 ET1003.305
12:57 ET24033.305
01:00 ET139053.295
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRMD
CorMedix Inc
180.3M
-3.8x
---
United StatesCPLFY
Cipla Ltd
14.1B
0.0x
---
United StatesDBVT
Dbv Technologies SA
139.6M
-1.5x
---
United StatesASMB
Assembly Biosciences Inc
60.9M
-0.7x
---
United StatesIXHL
Incannex Healthcare Inc
69.5M
-772.1x
---
United StatesELTP
Elite Pharmaceuticals Inc
184.6M
9.5x
---
As of 2024-02-22

Company Information

CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on developing its product DefenCath, which is an antibacterial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic emodialysis. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL intended for the reduction of catheter-related infections and thrombosis in patients requiring central venous catheters CVCs in clinical settings, such as hemodialysis, total parenteral nutrition and oncology. In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.

Contact Information

Headquarters
300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
Phone
908-517-9500
Fax
302-636-5454

Executives

Independent Chairman of the Board
Myron Kaplan
Director
Joseph Todisco
Chief Financial Officer, Executive Vice President
Matthew David
Executive Vice President, Head of Clinical and Medical Affairs
Elizabeth Massonhurlburt
Executive Vice President, Chief Commercial Officer
Erin Mistry

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$180.3M
Revenue (TTM)
$29.7K
Shares Outstanding
54.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.83
EPS
$-0.86
Book Value
$1.29
P/E Ratio
-3.8x
Price/Sales (TTM)
6,071.8
Price/Cash Flow (TTM)
---
Operating Margin
-140,330.90%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.